HBW Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History

HBW Advisory Services’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$292K	Sell	1,536 -58	-4%	-$9.97K	0.03%	388
2026 Q1	$269K	Sell	1,594 -4,490	-74%	-$768K	0.03%	371
2025 Q4	$1.03M	Buy	+6,084	New	+$988K	0.11%	184
2023 Q3	–	Sell	-1,678	Closed	-$213K	–	320
2023 Q2	$213K	Sell	1,678 -365	-18%	-$47.4K	0.05%	273
2023 Q1	$264K	Sell	2,043 -22	-1%	-$2.88K	0.07%	221
2022 Q4	$271K	Buy	+2,065	New	+$267K	0.07%	212
2021 Q2	–	Sell	-19,078	Closed	-$2.87M	–	263
2021 Q1	$2.87M	Buy	+19,078	New	+$3.03M	0.76%	48
2020 Q1	–	Sell	-1,761	Closed	-$212K	–	124
2019 Q4	$212K	Buy	+1,761	New	+$196K	0.12%	129

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

HBW Advisory Services's IBB Position: Q2 2026 in Review

HBW Advisory Services reduced its iShares Biotechnology ETF (IBB) stake by 3.6% in Q2 2026, selling an estimated $9.97K and leaving 1,536 shares worth $292K. The position accounts for 0.03% of the portfolio, ranked #388.

HBW Advisory Services first reported a position in IBB in Q4 2019 and has held it in 8 quarters since. The position peaked at $2.87M in Q1 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

HBW Advisory Services held 1,536 shares of iShares Biotechnology ETF worth $292K as of Q2 2026.
HBW Advisory Services sold 58 iShares Biotechnology ETF shares in Q2 2026, an estimated $9.97K.
iShares Biotechnology ETF made up 0.03% of HBW Advisory Services's portfolio in Q2 2026, its #388 holding.
HBW Advisory Services first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 8 quarters since.
HBW Advisory Services's iShares Biotechnology ETF position peaked at $2.87M in Q1 2021.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on HBW Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.